Cargando…

Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators

BACKGROUND: India has made great progress towards the elimination of lymphatic filariasis. By 2015, most endemic districts had completed at least five annual rounds of mass drug administration (MDA). The next challenge is to determine when MDA can be stopped. We performed a simulation study with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jambulingam, Purushothaman, Subramanian, Swaminathan, de Vlas, S. J., Vinubala, Chellasamy, Stolk, W. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022201/
https://www.ncbi.nlm.nih.gov/pubmed/27624157
http://dx.doi.org/10.1186/s13071-016-1768-y
_version_ 1782453476723261440
author Jambulingam, Purushothaman
Subramanian, Swaminathan
de Vlas, S. J.
Vinubala, Chellasamy
Stolk, W. A.
author_facet Jambulingam, Purushothaman
Subramanian, Swaminathan
de Vlas, S. J.
Vinubala, Chellasamy
Stolk, W. A.
author_sort Jambulingam, Purushothaman
collection PubMed
description BACKGROUND: India has made great progress towards the elimination of lymphatic filariasis. By 2015, most endemic districts had completed at least five annual rounds of mass drug administration (MDA). The next challenge is to determine when MDA can be stopped. We performed a simulation study with the individual-based model LYMFASIM to help clarify this. METHODS: We used a model-variant for Indian settings. We considered different hypotheses on detectability of antigenaemia (Ag) in relation to underlying adult worm burden, choosing the most likely hypothesis by comparing the model predicted association between community-level microfilaraemia (Mf) and antigenaemia (Ag) prevalence levels to observed data (collated from literature). Next, we estimated how long MDA must be continued in order to achieve elimination in different transmission settings and what Mf and Ag prevalence may still remain 1 year after the last required MDA round. The robustness of key-outcomes was assessed in a sensitivity analysis. RESULTS: Our model matched observed data qualitatively well when we assumed an Ag detection rate of 50 % for single worm infections, which increases with the number of adult worms (modelled by relating detection to the presence of female worms). The required duration of annual MDA increased with higher baseline endemicity and lower coverage (varying between 2 and 12 rounds), while the remaining residual infection 1 year after the last required treatment declined with transmission intensity. For low and high transmission settings, the median residual infection levels were 1.0 % and 0.4 % (Mf prevalence in the 5+ population), and 3.5 % and 2.0 % (Ag prevalence in 6–7 year-old children). CONCLUSION: To achieve elimination in high transmission settings, MDA must be continued longer and infection levels must be reduced to lower levels than in low-endemic communities. Although our simulations were for Indian settings, qualitatively similar patterns are also expected in other areas. This should be taken into account in decision algorithms to define whether MDA can be interrupted. Transmission assessment surveys should ideally be targeted to communities with the highest pre-control transmission levels, to minimize the risk of programme failure. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13071-016-1768-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5022201
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50222012016-09-20 Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators Jambulingam, Purushothaman Subramanian, Swaminathan de Vlas, S. J. Vinubala, Chellasamy Stolk, W. A. Parasit Vectors Research BACKGROUND: India has made great progress towards the elimination of lymphatic filariasis. By 2015, most endemic districts had completed at least five annual rounds of mass drug administration (MDA). The next challenge is to determine when MDA can be stopped. We performed a simulation study with the individual-based model LYMFASIM to help clarify this. METHODS: We used a model-variant for Indian settings. We considered different hypotheses on detectability of antigenaemia (Ag) in relation to underlying adult worm burden, choosing the most likely hypothesis by comparing the model predicted association between community-level microfilaraemia (Mf) and antigenaemia (Ag) prevalence levels to observed data (collated from literature). Next, we estimated how long MDA must be continued in order to achieve elimination in different transmission settings and what Mf and Ag prevalence may still remain 1 year after the last required MDA round. The robustness of key-outcomes was assessed in a sensitivity analysis. RESULTS: Our model matched observed data qualitatively well when we assumed an Ag detection rate of 50 % for single worm infections, which increases with the number of adult worms (modelled by relating detection to the presence of female worms). The required duration of annual MDA increased with higher baseline endemicity and lower coverage (varying between 2 and 12 rounds), while the remaining residual infection 1 year after the last required treatment declined with transmission intensity. For low and high transmission settings, the median residual infection levels were 1.0 % and 0.4 % (Mf prevalence in the 5+ population), and 3.5 % and 2.0 % (Ag prevalence in 6–7 year-old children). CONCLUSION: To achieve elimination in high transmission settings, MDA must be continued longer and infection levels must be reduced to lower levels than in low-endemic communities. Although our simulations were for Indian settings, qualitatively similar patterns are also expected in other areas. This should be taken into account in decision algorithms to define whether MDA can be interrupted. Transmission assessment surveys should ideally be targeted to communities with the highest pre-control transmission levels, to minimize the risk of programme failure. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13071-016-1768-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-09-13 /pmc/articles/PMC5022201/ /pubmed/27624157 http://dx.doi.org/10.1186/s13071-016-1768-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Jambulingam, Purushothaman
Subramanian, Swaminathan
de Vlas, S. J.
Vinubala, Chellasamy
Stolk, W. A.
Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators
title Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators
title_full Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators
title_fullStr Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators
title_full_unstemmed Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators
title_short Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators
title_sort mathematical modelling of lymphatic filariasis elimination programmes in india: required duration of mass drug administration and post-treatment level of infection indicators
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022201/
https://www.ncbi.nlm.nih.gov/pubmed/27624157
http://dx.doi.org/10.1186/s13071-016-1768-y
work_keys_str_mv AT jambulingampurushothaman mathematicalmodellingoflymphaticfilariasiseliminationprogrammesinindiarequireddurationofmassdrugadministrationandposttreatmentlevelofinfectionindicators
AT subramanianswaminathan mathematicalmodellingoflymphaticfilariasiseliminationprogrammesinindiarequireddurationofmassdrugadministrationandposttreatmentlevelofinfectionindicators
AT devlassj mathematicalmodellingoflymphaticfilariasiseliminationprogrammesinindiarequireddurationofmassdrugadministrationandposttreatmentlevelofinfectionindicators
AT vinubalachellasamy mathematicalmodellingoflymphaticfilariasiseliminationprogrammesinindiarequireddurationofmassdrugadministrationandposttreatmentlevelofinfectionindicators
AT stolkwa mathematicalmodellingoflymphaticfilariasiseliminationprogrammesinindiarequireddurationofmassdrugadministrationandposttreatmentlevelofinfectionindicators